English  |  正體中文  |  简体中文  |  Items with full text/Total items : 16984/19280 (88%)
Visitors : 7715447      Online Users : 540
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/31690


    標題: Cisplatin Nephrotoxicity Might Have a Sex Difference. An analysis Based on Women's Sex Hormone Changes
    作者: Chen, Wei-Yu
    Hsiao, Ching-Hsing
    Chen, Yi-Chen
    Ho, Chung-Han
    Wang, Jhi-Joung
    Hsing, Chung-Hsi
    Wang, Hsien-Yi
    Kan, Wei-Chih
    Wu, Chia-Chun
    貢獻者: Chi Mei Med Ctr, Dept Hematol & Oncol
    Chi Mei Hosp, Dept Ophthalmol
    Chi Mei Med Ctr, Dept Med Res
    Chia Nan Univ Pharm & Sci, Dept Pharm
    Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm
    Chi Mei Med Ctr, Dept Med Res
    Chi Mei Med Ctr, Dept Anesthesiol
    Taipei Med Univ, Dept Anesthesiol, Coll Med
    Chi Mei Med Ctr, Dept Nephrol, Dept Internal Med
    Chia Nan Univ Pharm & Sci, Dept Sports Management, Coll Leisure & Recreat Management
    Chung Hwa Univ Med Technol, Dept Biol Sci & Technol
    關鍵字: cisplatin
    nephrotoxicity
    sex difference
    chronic kidney disease
    acute kidney disease
    日期: 2017
    上傳時間: 2018-11-30 15:53:01 (UTC+8)
    出版者: Ivyspring Int Publ
    摘要: Background: A sex difference in cisplatin-induced nephrotoxicity (CIN) has been reported in human and animal studies. We examined in humans whether it is associated with sex-hormone changes. Methods: In this retrospective nationwide cohort study, we used Taiwan's National Health Insurance Research Database (NHIRD) to identify patients with a history of malignancy and cisplatin treatment. Patients diagnosed with kidney disease before cisplatin treatment and those with sex-organ malignancies were excluded. A diagnosis of kidney disease within 90 days after the first administration of cisplatin was the study outcome. Risk factors were estimated using a Cox regression model. Subgroup analyses were performed based on different women's estrogen levels in phases of childbearing, perimenopause, and postmenopause. Results: A retrospective analysis of the records of 3973 men (mean age: 56.15 +/- 12.85 years) and 1154 women (mean age: 56.31 +/- 12.40 years) showed that 1468 (36.95%) men and 451 (39.08%) women had a new diagnosis of kidney disease. The risk factors were being > 55 years old, a high comorbidity score, and a history of aminoglycoside treatment. Only postmenopausal women had a significantly higher risk of kidney injury (hazard ratio: 1.28; 95% CI: 1.02-1.61) than did men. Conclusions: Perimenopausal women have a significantly higher risk of CIN than do men, which might be explained by women's higher levels of estrogen. Additional studies on the underlying mechanisms of the sex difference of CIN are needed.
    Appears in Collections:[醫務管理系(所)] 期刊論文
    [藥學系(所)] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML104View/Open
    jca.20083.pdf410KbAdobe PDF0View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback